Mytide Therapeutics specializes in the development and production of peptides for various applications in biotechnology and pharmaceuticals. The company provides targeted solutions for drug delivery and therapeutic interventions, enhancing treatment efficacy and patient outcomes.
Funding
$8.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The development of peptide-based therapeutics and drug delivery systems is often hindered by challenges in peptide synthesis, modification, and purification, leading to increased development costs and timelines. Efficient and scalable production of high-quality peptides with specific modifications remains a significant bottleneck in the field.
Solution
Mytide Therapeutics offers custom peptide synthesis and modification services to accelerate the development of peptide-based drugs and drug delivery systems. The company leverages advanced solid-phase peptide synthesis (SPPS) techniques and proprietary purification methods to produce peptides with high purity and yield. Mytide's services include peptide design, synthesis of modified peptides (e.g., PEGylated, cyclized), and analytical characterization. By providing tailored peptide solutions, Mytide Therapeutics enables researchers and pharmaceutical companies to overcome synthetic challenges and advance their therapeutic programs.
Target Audience
Mytide Therapeutics serves pharmaceutical companies, biotechnology firms, and academic researchers involved in drug discovery, peptide therapeutics, and drug delivery system development.
Features
- Custom peptide synthesis with a wide range of amino acid modifications
- Solid-phase peptide synthesis (SPPS) using Fmoc chemistry
- High-throughput peptide synthesis for library screening
- Peptide cyclization and PEGylation services
- Analytical characterization including HPLC, mass spectrometry, and amino acid analysis
- GMP-grade peptide synthesis for clinical trials